Topical cream-based oxyresveratrol in the treatment of cutaneous HSV-1 infection in mice

Chuanasa, 2008, Anti-herpes simplex virus (HSV-1) activity of oxyresveratrol derived from Thai medicinal plant: mechanism of action and therapeutic efficacy on cutaneous HSV-1 infection in mice, Antiviral Res., 80, 62, 10.1016/j.antiviral.2008.05.002 De Clercq, E., 1984. Topical treatment of cutaneous herpes simplex virus infection in hairless mice with (E)-5-(2-bromovinyl)-2′-deoxyuridine and related compounds. Antimicrob. Agents Chemother. 155–159. De Clercq, 2001, Molecular targets for antiviral agents, J. Pharmacol. Exp. Ther., 297, 1 De Clercq, 2004, Antiviral drugs in current clinical use, J. Clin. Virol., 30, 115, 10.1016/j.jcv.2004.02.009 Galasso, 1997 Giirol, 1996, Percutaneous absorption of ketoprofen. I. In vitro release and percutaneous absorption of ketoprofen from different ointment bases, Pharm. Acta Helvetiae, 71, 205, 10.1016/0031-6865(96)00011-8 Greco, 2007, Novel targets for the development of anti-herpes compounds, Infect. Disord. Drug Targets, 7, 11, 10.2174/187152607780090766 Herold, 1995, Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding, Virology, 206, 1108, 10.1006/viro.1995.1034 Khan, 2005, Extracts and molecules from medicinal plants against herpes simplex viruses, Antiviral Res., 67, 107, 10.1016/j.antiviral.2005.05.002 Kurokawa, 1993, Antiviral traditional medicines against herpes simplex virus (HSV-1), poliovirus, and measles virus and their therapeutic efficacies for HSV-1 infection in mice, Antiviral Res., 22, 175, 10.1016/0166-3542(93)90094-Y Kurokawa, 1998, Purification and characterization of eugeniin as an anti-herpes virus compound from Geum japonicum and Syzygium aromaticum, J. Pharmacol. Exp. Ther., 284, 728 Kurokawa, 1999, Anti-herpes simplex virus activity of moronic acid purified from Rhus javanica in vitro and in vivo, J. Pharmacol. Exp. Ther., 289, 72 Likhitwitayawuid, 2005, Phenolics with antiviral activity from Millettia erythrocalyx and Artocarpus lakoocha, Nat. Prod. Res., 19, 177, 10.1080/14786410410001704813 Lipipun, 2003, Efficacy of Thai medicinal plant extracts against herpes simplex virus type 1 infection in vitro and in vivo, Antiviral Res., 60, 175, 10.1016/S0166-3542(03)00152-9 Sangkitporn, 1993, Treatment of recurrent genital herpes simplex virus infections with Clinacanthus nutans extract, Bull. Dept. Med. Serv., 18, 226 Sangkitporn, 1995, Treatment of herpes zoster with Clinacanthus nutans (BiPhya Yaw) extract, J. Med. Assoc. Thai, 78, 624 Sasivimolphan, 2009, Inhibitory activity of oxyresveratrol on wild-type and drug-resistant varicella-zoster virus replication in vitro, Antiviral Res., 84, 95, 10.1016/j.antiviral.2009.07.010 Shiraki, 1988, Effects of caffeine on herpes simplex virus, Intervirology, 29, 235 Shiraki, 1991, Immunosuppressive dose of azathioprine inhibits replication of human cytomegalovirus in vitro, Arch. Virol., 117, 165, 10.1007/BF01310762 Spruance, 1986, Comparison of foscarnet cream, acyclovir cream, and acyclovir ointment in the topical treatment of experimental cutaneous herpes simplex virus type 1 infection, Antimicrob. Agents Chemother., 30, 196, 10.1128/AAC.30.1.196 Spurance, 1990, Topical treatment of cutaneous herpes simplex virus infections, Antiviral Res., 14, 305, 10.1016/0166-3542(90)90050-H Sritularak, 1998, Tyrosinase inhibitors from Artocarpus lakoocha, Thai J. Pharm. Sci., 22, 149 Suzuki, 2006, Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus, Antiviral Res., 72, 157, 10.1016/j.antiviral.2006.05.001 Tennican, 1980, Topical zinc in the treatment of mice infected intravaginally with herpes genitalis virus, Proc. Soc. Exp. Biol. Med., 164, 593, 10.3181/00379727-164-40922 Vanden Berghe, 1993, Antiviral agents from higher plants and an example of structure–activity relationship of 3-methoxy flavones, 405